Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAscendis Pharma A/S Reports Third Quarter 2019 Financial ResultsPREV STORYCRISPR Gene Editing Eliminates Herpes Simplex Virus and JC Virus, Demonstrating Feasibility of a Potential Functional Cure